{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:24:01Z","timestamp":1791390241564,"version":"4.3.3"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) and autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy have received increasing attention in recent years. However, the coexistence of anti-MOG and anti-GFAP antibodies has rarely been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case<\/jats:title>\n                    <jats:p>A 53-year-old man presented with a headache, slow reaction, nonsense talk, unsteady walking without diplopia or decreased vision. Lumbar puncture revealed the presence of anti-MOG and anti-GFAP antibodies in the cerebrospinal fluid. Magnetic resonance imaging revealed multiple high signal intensities in the white matter. The patient was diagnosed with MOGAD syndrome with overlapping GFAP-IgG. Treatment comprised high-dose methylprednisolone and efgartigimod therapy, followed by gradual tapering of oral prednisolone and the addition of an immunosuppressant, leading to symptomatic improvement and sustained remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We report a case of MOGAD-overlapping GFAP IgG treated with combination therapy of steroids and efgartigimod. This case enhances our understanding of the clinical manifestations of overlapping syndromes and expands the treatment options for this disorder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1624660","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T06:28:00Z","timestamp":1763360880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Efgartigimod as an additional therapy for MOG antibody-associated disease overlapping GFAP-IgG"],"prefix":"10.3389","volume":"16","author":[{"given":"Yun","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"Uzawa","year":"2024","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100913","article-title":"Humoral signatures of MOG-antibody\u2013associated disease track with age and disease activity","volume":"4","author":"Spatola","year":"2023","journal-title":"Cell Rep Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamaneurol.2021.0926","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis","volume":"78","author":"Fang","year":"2021","journal-title":"JAMA Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/brain\/awac436","article-title":"Prognostic predictors of GFAP-IgG seropositive autoimmune astrocytopathy","volume":"146","author":"Long","year":"2023","journal-title":"Brain"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1140872","article-title":"Clinical analysis of 173 pediatric patients with antibody-mediated autoimmune diseases of the central nervous system: a single-center cohort study","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalized myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1016\/S2352-3026(23)00030-2","article-title":"Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"2","author":"Newland","year":"2023","journal-title":"Lancet Haematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/jns.12589","article-title":"FcRn antagonist efgartigimod in CIDP: first clinical trial design","volume":"28","author":"Van Lieverloo","year":"2023","journal-title":"J Peripher Nerv Syst"},{"key":"B9","doi-asserted-by":"publisher","first-page":"eadj3548","DOI":"10.1126\/scitranslmed.adj3548","article-title":"FcRn blockade by efgartigimod suppresses pathogenic autoantibodies in pemphigus","volume":"16","author":"Ellebrecht","year":"2024","journal-title":"Sci Transl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02896-6","article-title":"Distinct features of B cell receptors in neuromyelitis optica spectrum disorder among CNS inflammatory demyelinating diseases","volume":"20","author":"Kim","year":"2023","journal-title":"J Neuroinflammation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1093\/brain\/awaa102","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study","volume":"143","author":"Takai","year":"2020","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-023-02678-7","article-title":"New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis","volume":"147","author":"Guo","year":"2024","journal-title":"Acta Neuropathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1098","DOI":"10.1212\/NXI.0000000000001098","article-title":"Paraneoplastic GFAP autoimmunity: frequency and phenotype","volume":"9","author":"Dubey","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09869-2","article-title":"Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy","volume":"267","author":"Ding","year":"2020","journal-title":"J Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s42466-021-00145-w","article-title":"Paraneoplastic encephalomyeloradiculits with multiple autoantibodies against ITPR-1, GFAP and MOG: case report and literature review","volume":"3","author":"Cirkel","year":"2021","journal-title":"Neurol Res Pract"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e000236","DOI":"10.1136\/bmjno-2021-000236","article-title":"Coexistent anti-GFAP and anti-MOG antibodies presenting with isolated meningitis and papillitis: more support for overlapping pathophysiology","volume":"4","author":"Martin","year":"2022","journal-title":"BMJ Neurol Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12883-021-02381-8","article-title":"Overlapping syndrome mimicking infectious meningoencephalitis in a patient with MOG and GFAP IgG","volume":"21","author":"Ji","year":"2021","journal-title":"BMC Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12633-5","article-title":"Clinical characteristics of overlapping syndrome in patients with GFAP-IgG and MOG-IgG: a case series of 8 patients and literature review","volume":"271","author":"Fang","year":"2024","journal-title":"J Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103451","article-title":"FcRn antagonists in autoimmune diseases: current evidence and clinical practice","volume":"23","author":"Smith","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ana.26310","article-title":"GFAP autoimmunity: a French cohort study","volume":"91","author":"Flanagan","year":"2022","journal-title":"Ann Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803396","article-title":"Clinical metagenomic next-generation sequencing for diagnosis of neurological infections","volume":"380","author":"Wilson","year":"2019","journal-title":"New Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00031-5","article-title":"Contemporary approaches to diagnosing and managing antibody-mediated neurologic disorders","volume":"3","author":"Titulaer","year":"2024","journal-title":"Lancet Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1164877","article-title":"Case report: Autoimmune glial fibrillary acidic protein astrocytopathy with overlapping autoimmune syndrome","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"E437","DOI":"10.1503\/cmaj.141040","article-title":"Hypoglycemic encephalopathy","volume":"187","author":"Kuriyama","year":"2015","journal-title":"Can Med Assoc J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s13256-023-04191-7","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and Human Immunodeficiency virus infection: dilemmas in diagnosis and management: a case series","volume":"17","author":"Gadama","year":"2023","journal-title":"J Med Case Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.950522","article-title":"Case report: Revealing a special and rare autoimmune GFAP astrocytopathy in the spinal cord succeeding Neurobrucellosis infection","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578287","article-title":"Rapid symptom relief in autoimmune encephalitis with efgartigimod: a three-patient case series","volume":"389","author":"Bettini","year":"2024","journal-title":"J Neuroimmunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1624660\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T06:28:06Z","timestamp":1763360886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1624660\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2025.1624660"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1624660","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"article-number":"1624660"}}